Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Swine Healthcare Market Size, Growth, Analysis, Research: By Product: Diagnostic Tests, Therapeutics; By Diseases: Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Others; By Route of Administration; By Distribution Channel; Regional Analysis; Competitive Landscape: Industry Events and Developments; 2022-2027

Global Swine Healthcare Market Outlook

The global swine healthcare market size is further expected to grow in the forecast period of 2022-2027 at a CAGR of 7.90%.

 

Growing Research and Development Activities to Increase Diagnostic Efficiencies to Augment the Global Swine Healthcare Industry

Diagnostic tests are crucial for swine diseases for early detection and subsequent start of the treatment procedures. The surge in the cases of swine fever and swine influenza, and associated deaths has led to the enhancement of swine disease diagnostic facilities in hospitals and clinics. Over the forecast period, the technological advancements in diagnostic procedures in laboratories to increase the understanding of swine disease investigation algorithm are likely to bolster the segment’s growth.

 

Moreover, the anticipated increase in the incorporation of diagnostic imaging in veterinary hospitals is likely to generate demand for accessories and diagnostic equipment in the coming years, supporting the overall swine healthcare market. The increasing research and development activities in laboratory diagnostics, particularly for African swine fever to facilitate quick and efficient diagnostics to enhance the recovery process from the potential fatality are further propelling the segment’s growth. 

 

North America Leads with a Substantial Share in the Market for Swine Healthcare

The market in the North America region is being driven by the policies of the governments which are favouring the research and development activities in therapeutic and pharmaceutical laboratories committed towards the development of swine disease treatment medications. The United States is one of the highest spenders on healthcare which is a major driving factor of the market. 

 

In addition to this, the United States has the largest pork eating population. This factor is further escalating concerns pertaining to swine healthcare. Furthermore, the thriving commercial pork production in the region owing to the increasing exports and rising domestic demand is likely to provide impetus to the market in the coming years. 

 

Market Segmentation

Swine healthcare is defined as an umbrella term which includes healthcare products, diagnostic kits, and treatment procedures, aimed towards bolstering comfort during various types of swine diseases. Swine disease can happen to both humans and pigs and require efficient treatment in order to prevent fatalities. The swine healthcare market has been divided based on product, diseases, and distribution channels, among others.  

 

Based on product, the market can be segmented into:

  • Diagnostic Tests (Further breakup by diagnostic test types)
    • Enzyme Linked Immuno-Sorbent Assay (ELISA)
    • Rapid Immuno Migration (RIM)
    • Agar Gel Immuno-Diffusion (AGID)
    • Polymerase Chain Reaction (PCR)
    • Diagnostic Imaging
    • Others
  • Therapeutics (Further breakup by therapeutics type)
    • Vaccines
    • Parasiticides
    • Anti-Infectives
    • Feed Additives
    • Others

 

By disease, the swine healthcare market has been divided into:

  • Exudative Dermatitis
  • Porcine Parvovirus
  • Coccidiosis
  • Swine Dysentery
  • Respiratory Diseases
  • Others

 

On the basis of route of administration, the market has been categorised into:

  • Injectable
  • Oral

 

The major distribution channels based on which the market has been segmented are as follows:

  • Veterinary Hospitals 
  • Retail Pharmacy 
  • Online

 

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Increasing Prevalence of Swine Diseases to Boost the Growth of the Swine Healthcare Industry

The global swine healthcare market is being driven by the increasing prevalence of respiratory diseases and swine dysentery. This is propelling the demand for swine healthcare products from hospitals and clinics in order to bolster the diagnostic and treatment process for timely recovery. Meanwhile, the robust promotion of government initiatives and schemes encouraging the development of vaccines to prevent swine flu and swine fever is further propelling the market growth. 

 

The anticipated increase in the research and development activities aimed towards the bringing innovative oral treatments to the market, owing to the increasing inclination towards minimally invasive treatment procedures, is likely to add to the market growth. The rising pork and beacon eating population is anticipated to propel the demand for healthy swine livestock in the forecast period which is likely to pose great impact on the swine healthcare market in the future. 

 

Key Players in the Global Market for Swine Healthcare

The report gives a detailed analysis of the following key players in the global market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

 

  • Boehringer Ingelheim International GmbH
  • Phibro Animal Health Corporation
  • Merck & Co., Inc.,
  • Ceva Animal Health, LLC
  • IDEXX Laboratories, Inc
  • Virbac Corporation
  • Others

 

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Diseases
  • Route of Administration
  • Distribution Channel    
  • Region
Breakup by Product
  • Diagnostic Tests
    • Enzyme Linked Immuno-Sorbent Assay (ELISA)
    • Rapid Immuno Migration (RIM)
    • Agar Gel Immuno-Diffusion (AGID)
    • Polymerase Chain Reaction (PCR)
    • Diagnostic Imaging
    • Others
  • Therapeutics
    • Vaccines
    • Parasiticides
    • Anti-Infectives
    • Feed Additives
    • Others
Breakup by Diseases
  • Exudative Dermatitis
  • Coccidiosis
  • Respiratory Diseases
  • Swine Dysentery
  • Porcine Parvovirus
  • Others
Breakup by Route of Administration
  • Injectable
  • Oral
Breakup by Distribution Channel    
  • Veterinary Hospitals 
  • Retail Pharmacy 
  • Online
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Boehringer Ingelheim International GmbH
  • Phibro Animal Health Corporation
  • Merck & Co., Inc.,
  • Ceva Animal Health, LLC
  • IDEXX Laboratories, Inc
  • Virbac Corporation
  • Others

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface 
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions   
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments  
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Region
7    Industry Opportunities and Challenges  
8    Global Swine Healthcare Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Swine Healthcare Historical Market (2017-2021) 
    8.3    Global Swine Healthcare Market Forecast (2022-2027)
    8.4    Global Swine Healthcare Market by Product
        8.4.1    Diagnostic Tests
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
            8.4.1.4    Breakup by Diagnostic Tests Type
                8.4.1.4.1    Enzyme Linked Immuno-Sorbent Assay (ELISA)
                8.4.1.4.2    Rapid Immuno Migration (RIM)
                8.4.1.4.3    Agar Gel Immuno-Diffusion (AGID)
                8.4.1.4.4    Polymerase Chain Reaction (PCR)
                8.4.1.4.5    Diagnostic Imaging
                8.4.1.4.6    Others
        8.4.2    Therapeutics
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
            8.4.2.4    Breakup by Therapeutics Type
                8.4.2.4.1    Vaccines
                8.4.2.4.2    Parasiticides
                8.4.2.4.3    Anti-Infectives
                8.4.2.4.4    Feed Additives
                8.4.2.4.5    Others
    8.5    Global Swine Healthcare Market by Diseases
        8.5.1    Exudative Dermatitis
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027) 
        8.5.2    Coccidiosis
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Respiratory Diseases
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Swine Dysentery
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2017-2021)
            8.5.4.3    Forecast Trend (2022-2027)
        8.5.5    Porcine Parvovirus
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2017-2021)
            8.5.5.3    Forecast Trend (2022-2027)
        8.5.6    Others
    8.6    Global Swine Healthcare Market by Route of Administration
        8.6.1    Injectable
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Oral
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
    8.7    Global Swine Healthcare Market by Distribution Channel
        8.7.1    Veterinary Hospitals 
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2017-2021)
            8.7.1.3    Forecast Trend (2022-2027)
        8.7.2    Retail Pharmacy 
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2017-2021)
            8.7.2.3    Forecast Trend (2022-2027)
        8.7.3    Online
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2017-2021)
            8.7.3.3    Forecast Trend (2022-2027)
    8.8    Global Swine Healthcare Market by Region
        8.8.1    Market Share
            8.8.1.1    North America
            8.8.1.2    Europe
            8.8.1.3    Asia Pacific
            8.8.1.4    Latin America
            8.8.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Boehringer Ingelheim International GmbH
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Phibro Animal Health Corporation
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Merck & Co., Inc.,
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Ceva Animal Health, LLC
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    IDEXX Laboratories, Inc
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Virbac Corporation
            11.2.6.1    Company Overview
            11.2.6.2    Product Portfolio
            11.2.6.3    Demographic Reach and Achievements
            11.2.6.4    Certifications
        11.2.7    Others
12    Industry Events and Developments


List of Key Figures and Tables

1.    Global Swine Healthcare Market: Key Industry Highlights, 2017 and 2027
2.    Global Swine Healthcare Historical Market: Breakup by Product (USD Million), 2017-2021
3.    Global Swine Healthcare Market Forecast: Breakup by Product (USD Million), 2022-2027
4.    Global Swine Healthcare Historical Market: Breakup by Diseases (USD Million), 2017-2021
5.    Global Swine Healthcare Market Forecast: Breakup by Diseases (USD Million), 2022-2027
6.    Global Swine Healthcare Historical Market: Breakup by Route of Administration (USD Million), 2017-2021
7.    Global Swine Healthcare Market Forecast: Breakup by Route of Administration (USD Million), 2022-2027
8.    Global Swine Healthcare Historical Market: Breakup by Distribution Channel (USD Million), 2017-2021
9.    Global Swine Healthcare Market Forecast: Breakup by Distribution Channel (USD Million), 2022-2027
10.    Global Swine Healthcare Historical Market: Breakup by Region (USD Million), 2017-2021
11.    Global Swine Healthcare Market Forecast: Breakup by Region (USD Million), 2022-2027
12.    North America Swine Healthcare Historical Market: Breakup by Country (USD Million), 2017-2021
13.    North America Swine Healthcare Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Europe Swine Healthcare Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Europe Swine Healthcare Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Asia Pacific Swine Healthcare Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Asia Pacific Swine Healthcare Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Latin America Swine Healthcare Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Latin America Swine Healthcare Market Forecast: Breakup by Country (USD Million), 2022-2027
20.    Middle East and Africa Swine Healthcare Historical Market: Breakup by Country (USD Million), 2017-2021
21.    Middle East and Africa Swine Healthcare Market Forecast: Breakup by Country (USD Million), 2022-2027
22.    Global Swine Healthcare Market Structure.

Key Questions Answered in the Report

The market is estimated to grow at a CAGR of 7.90% between 2022 and 2027.

The market is estimated to witness a healthy growth in the forecast period of 2022-2027. 

The growing research and development activities aimed towards developing therapeutics for swine disease treatment are likely to be the key trends in the market.  

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major market drivers include the increasing prevalence of swine dysentery and swine fever, increasing demand for pork in western countries, and rapid development of oral treatment for swine diseases. 

Diagnostic tests and therapeutics are the different segments based on product.

Exudative dermatitis, coccidiosis, respiratory diseases, swine dysentery, and porcine parvovirus, among others is the segmentation of market based on disease.

Injectable and oral are the routes of administration based on which the market has been bifurcated.

Veterinary hospitals, retail pharmacy, and online are the different channels of distribution considered in the market report. 

The major players in the industry are Boehringer Ingelheim International GmbH, Phibro Animal Health Corporation, Merck & Co., Inc., Ceva Animal Health, LLC, IDEXX Laboratories, Inc, and Virbac Corporation, among others. 

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER